Due to its profound effect on metabolism, gamitrinib elicited a mitochondrial unfolded stress response with up-regulation of CEBP/beta and CHOP that in turn suppressed NF-κB activity in GBM cells. This evidence concerns the gene NFKB1 and glioblastoma.